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Précis 21 
Ectropion is an abnormal eversion of the eyelid margin. The understanding of the 22 
underlying pathophysiological mechanism is the key to a successful surgical 23 
treatment.24 
ABSTRACT 25 
 26 
Purpose: Ectropion is one of the most common eyelid malpositions. The treatment 27 
of ectropion is still a subject of controversy. The authors reviewed the literature about 28 
ectropion, including definition, diagnosis, pathophysiological mechanisms, 29 
classification and surgical treatments. 30 
Methods: A literature search was performed on the MEDLINE database using the 31 
keywords ectropion, eyelid malposition, cicatricial ectropion, congenital ectropion, 32 
involucional ectropion, mechanical ectropion, tarsal strip; lazy-T; canthoplasty, 33 
canthopexy, skin flaps, skin grafts. Only articles in english were included.  34 
Results: There is no consensus about the best surgical treatment for this eyelid 35 
malposition, however, we know that the identification of the anatomic abnormality 36 
associated is the most important point to chose the correct surgical treatment. The 37 
literature on the treatment of ectropion mainly includes descriptions of surgical 38 
techniques without objective measurements of the results, and uncontrolled studies.  39 
Conclusions: The scientific literature on ectropion is vast, however there is a need 40 
for quantitative studies on the effects of ectropion correction using different surgical 41 
techniques. 42 
 Ectropion is an eversion (outward turning) of the eyelid margin. This lid 43 
malposition may affect the lower or upper lid and leads to cosmetic and functional 44 
deficits, such as conjunctival hyperemia, corneal exposure, eye irritation, epiphora, 45 
chronic conjunctivitis, and in rare cases visual loss. It can be medial or lacrimal, 46 
lateral or complete (involving the entire eyelid).1,2 47 
 48 
METHODS OF LITERATURE SEARCH   49 
 A literature search was performed on the MEDLINE database using the 50 
keywords ectropion, eyelid malposition, cicatricial ectropion, congenital ectropion, 51 
involucional ectropion, mechanical ectropion, tarsal strip; lazy-T; canthoplasty, 52 
canthopexy, skin flaps, skin grafts. Only articles in english were included. 53 
 The research adhered to the tenets of the Declaration of Helsinki and was 54 
approved by the Ethics Committee of the Hospital de Braga, Braga, Portugal. An 55 
informed consent was obtained from patients whose photos were used in this article. 56 
 57 
CLASSIFICATION OF ECTROPION 58 
 59 
 Ectropion is usually classified as congenital, involutional, cicatricial, 60 
mechanical and paralytic.1,2 These categories are not absolute and some cases fit in 61 
more than one type. For instance, a four-lid ectropion in a newborn with lamellar 62 
ichthyosis can be considered as a congenital or a cicatricial ectropion. Similarly, the 63 
ectropion of a child born with an orbital cyst, which mechanically pushes the lid 64 
margin, may be seen as a congenital mechanical ectropion, and congenital facial 65 
palsies may cause a congenital paralytic ectropion.  66 
 From a therapeutic perspective, rather than focusing on the clinical categories 67 
it is more useful to look at the underlying pathophysiological mechanism (Table 1) 68 
because the correct identification of the anatomic abnormality associated with the lid 69 
margin malposition is the key to a successful surgical procedure.  70 
 71 
CONGENITAL ECTROPION 72 
 The designation “congenital ectropion” is used to name a variety of conditions 73 
with distinct pathophysiological mechanisms. A typical example is the so-called 74 
congenital upper eyelid eversion. This rare lid abnormality, usually present at birth, is 75 
characterized by eversion of both upper lid margins with prolapsed chemotic 76 
conjunctiva. It is typically symmetrical but some degree of asymmetry is not 77 
uncommon. Several factors have been implicated in its pathophysiology including 78 
trauma at birth, orbicularis hypotonia, posterior lamella vertical elongation and failure 79 
of the orbital septum to fuse with the levator aponeurosis with adipose tissue 80 
interposition. Most cases are not associated with ocular or general abnormalities. 81 
However, the incidence appears to be higher in Down syndrome. This peculiar form 82 
of upper lid ectropion responds well to conservative treatment such as topical 83 
ointments and lubricants, patching or temporary tarsorrhaphy.3-6  84 
 A totally different situation is represented by newborns with severe forms of 85 
lamellar ichthyosis. In these patients eyelid eversion is due to severe skin 86 
contraction. All four lids may undergo a severe form of cicatricial ectropion that might 87 
require early skin grafting in order to prevent corneal ulceration and eye perforation. 88 
Shortening of the anterior lamella is also implicated in other syndromes associated 89 
with congenital ectropion such as blepharophimosis (lower lid laterally)7, 90 
blepharocheilodontic syndrome (lower eyelids)8-10 and Down syndrome (upper and 91 
lower lids)11, as well a variety of sporadic congenital anomalies including craniofacial 92 
clefting.12 93 
  94 
INVOLUTIONAL ECTROPION 95 
 Involutional ectropion is the most frequent form of lower eyelid eversion, 96 
commonly found in aged patients. The Blue Mountain Eye Study assessed the 97 
prevalence and associations of ectropion in a large cohort of residents of Sydney, 98 
Australia (3654 people aged 49-97 years). Ectropion prevalence was higher in men 99 
(5.1%) than women (3.0%). The prevalence of lower eyelid ectropion increased with 100 
age, reaching 16.7% among patients above 80 years old.13 Damasceno studied a 101 
Brazilian population of 24 565 elderly people and found similar results, with a 102 
prevalence of 17.7% in subjects aged 80 years or more.14 103 
 Several factors have been implicated in the pathogenesis of this eyelid 104 
deformity, all related to an abnormal laxity of the lid support system including tarsal 105 
and orbital septum atrophy, thinning of the skin and subcutaneous tissues, 106 
elongation of the tarsus and pretarsal orbicularis, medial and lateral canthal tendon 107 
laxity and dehiscence, and elongation or desinsertion of the lower lid retractors.2 108 
Heimmel suggested that when these predisposing factors are present, the key to 109 
final lower eyelid position is the globe axial projection, with relatively exophthalmic 110 
eyes being more likely to develop tarsal ectropion.15 111 
 Histopathological studies have confirmed the role of age-related changes in 112 
the tarsal plate, inferior retractors, orbicularis oculi and lateral canthal tendon in the 113 
lids with involutional ectropion.16,17 The affected lid shows the presence of collagen 114 
degeneration and elastosis of the tarsal plate and canthal tendons, an increased 115 
amount of adipose tissue in the distal tarsus, and focal degeneration, fibrosis, and 116 
elastosis of the pretarsal orbicularis.18-20 In chronic sun exposure, actinic damage on 117 
the anterior lamella contributes as an additional factor to lower eyelid eversion in 118 
patients with involutional ectropion.21  119 
The evaluation of a patient with involutional ectropion should start with the 120 
inspection of the lid margin and the position of the puncta since one the first 121 
manifestations of lower eyelid ectropion is epiphora secondary to lacrimal punctum 122 
eversion. The patency of the puncta and lacrimal drainage system should always be 123 
examined.  124 
 The lower eyelid laxity can be detected using the “pinch test” and the “snap 125 
back test”. The result is abnormal if the lid can be distended more than 6 mm from 126 
the globe or does not briskly return to its natural position. The lateral canthus should 127 
form an acute angle and a rounded shape is indicative of lateral tendon elongation. If 128 
during traction of the lower lid there is lateral displacement of the lacrimal punctum 129 
towards the limbus, there is medial tendon laxity.2, 22 130 
 The condition of the lower lid skin is assessed by pulling the lower lid margin 131 
upwards. With traction the lid margin should reach a point at least 2 mm above the 132 
limbus. A relatively immobile margin indicates vertical shortening of the anterior 133 
lamella. This cicatricial component of the involutional ectropion is a common finding 134 
when the ectropion is present for a long period of time or can be the result of mild 135 
actinic changes of the skin. 2, 22 136 
  137 
CICATRICIAL ECTROPION  138 
 Cicatricial ectropion is caused by anterior lamella shortening. Depending on 139 
the etiologic mechanism, cicatricial entropion can affect the upper lids, the lower lids 140 
or both (as observed in same cases of ichthyosis). It  usuallyinvolves secondary 141 
eyelid scars resulting from trauma23, 24, burns25-27 or from a large contingent of skin 142 
diseases such as ichthyoses28, 29, discoid lupus erythematosus30, inherited 143 
epidermolysis bullosa31, generalized eruptive keratoacanthoma32-34, cutaneous 144 
leishmaniasis35, pityriasis rubra pilaris36, and pyoderma gangrenosum37, 38. 145 
 Postoperative complications of eyelid tumors39, 40, blepharoplasty41-44 and skin 146 
resurfacing45, 46 are also common causes of lower lid cicatricial ectropion. Other 147 
sources of skin damage resulting in ectropion are radiotherapy47, 48 and the use of 148 
drugs such as docetaxel49, fluorouracil50-52, anthrax53, prostaglandins54, 55, 149 
brimonidine55, betaxolol55, dorzolamide55, timolol55, and iopidine56.  150 
 151 
PARALYTIC ECTROPION 152 
 Paralytic ectropion is caused by the lack of normal innervation of the 153 
orbicularis muscle. Failure of normal lid closure with lower lid laxity and ectropion, 154 
upper eyelid retraction and brow ptosis are the clinical signs. The causes of seventh 155 
nerve palsy are myriad, but can be broadly divided, in the order of frequency, into 156 
idiopathic (Bell’s palsy), traumatic (birth canal trauma or forceps delivery, surgical 157 
trauma, facial and temporal bone fractures), infectious (herpes zoster, Lyme disease, 158 
HIV infection, polio, mumps, cytomegalovirus, mononucleosis, leprosy, cat scratch 159 
fever), and neoplastic (acoustic neuroma, cerebellopontine angle tumors).57  160 
 In paralytic ectropion due to surgical trauma, the timing for facial reanimation 161 
surgery is under debate. Watts et al advocate that rehabilitation surgery with gold 162 
weight implantation and lateral tarsal strip should be performed immediately, at the 163 
time of facial nerve sacrifice.58 164 
 165 
MECHANICAL ECTROPION 166 
 Mechanical ectropion is caused by eyelid tumors that evert the lower lid or 167 
inflammatory disorders that cause orbicularis spasm. Large tumors or cysts near the 168 
lid margin, acute proptosis with chemosis, eyelid and periocular edema, significant 169 
herniated orbital fat and traction on the lower eyelid skin from spectacles can 170 
mechanically cause ectropion. The treatment is directed at the cause.2, 59-62  171 
 172 
TREATMENT  173 
Lower or upper eyelid ectropions are usually managed with surgery. As 174 
mentioned before, the key for a successful surgical procedure is the correct 175 
preoperative identification of the underlying etiologic factor. Depending on the 176 
mechanism provoking the lid margin rotation, a variety of procedures are used to 177 
stabilize the lid margin. For instance, lower eyelid horizontal laxity with normal 178 
canthal tendon tonus can be addressed by pentagonal full thickness eyelid resection. 179 
If the lateral canthal tendon is abnormally lax tarsal strip procedures are indicated.1, 2, 180 
63, 64 This useful procedure is a variant of the old Bick’s lateral resection65 and 181 
consists of a lateral canthotomy and cantholysis; excision of skin and conjunctiva, 182 
leaving a free strip of tarsus; fixation of the tarsal strip to the periosteum of the lateral 183 
orbital wall; and reconstruction of the lateral canthus to create the appropriate height 184 
and tension of the lower eyelid.63, 66 Usually monofilament non-absorbable sutures 185 
are used 2, 64, 67, 68, but long-acting absorbable sutures will also work without 186 
recurrence of horizontal laxity. 66, 69, 70 187 
The repair of medial tendon laxity is more complicated than that of its lateral 188 
counterpart because of the intimate relation of the tendon with the canaliculi. The 189 
high rate of postoperative lacrimal problems following surgery on the medial canthus 190 
leads some surgeons to delay correction of the medial canthal tendon until laxity is 191 
advanced. Medial canthal tendon correction has been attempted by resection or 192 
plication of the tendon medial to the lower punctum, anchoring the tissue to either 193 
the anterior periosteum or posterior lacrimal crest.71-75 194 
 Lacrimal ectropion without horizontal laxity is classically treated with an 195 
excision of a diamond of conjunctiva and retractors below the punctum. If a 196 
horizontal laxity is present, a full-thickness wedge excision horizontally tight of the lid 197 
margin can be associated with the pentagon excision creating a lazy-T procedure. 198 
The wedge excision can be displaced laterally or be replaced by a tarsal strip. 76, 77 199 
In both procedures the role of lower lid retractor plication has been 200 
emphasized. Advanced tarsal ectropions require a large excision of conjunctiva and 201 
retractors by a posterior approach combined with everting sutures and horizontal 202 
tightening.78-80  203 
 Since cicatricial ectropion is due to an anterior lamella deficiency, various 204 
surgical techniques can be used to lengthen the underlying deformity. Z-plasties can 205 
be used to manage linear scars. 1, 2, 81 Large shortages of skin require local flaps 26, 206 
82-85 or skin grafts 27, 48, 86. There are a large variety of flaps that can be used to 207 
correct lower and upper ectropions depending on the location and extension of the 208 
cicatricial process. Free skin grafts may be obtained from the upper lid, retroauricular 209 
region, supraclavicular area or inner aspect of the upper arm.1, 2, 81 210 
 In severe lower eyelid ectropion, there is often inadequate muscular support 211 
for the pretarsal lower eyelid. When the pretarsal orbicularis muscle is damaged, a 212 
fascia lata sling is an option for supporting the lower lid.84  213 
 214 
CONCLUSION 215 
 A successful functional and cosmetic correction of ectropion depends on the 216 
understanding that ectropion is a group of eyelid malpositions that may have 217 
different etiological factors and may affect lateral, central or medial portion of the lids, 218 
alone or in combination. Surgery techniques must address the anatomic 219 
abnormalities responsible for the ectropion. The choice of the right procedure leads 220 
to a successful outcome for the patient which is the main goal.221 
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Table 1. Type of ectropion, affected lids and pathophysiologic mechanism. 
 
 
UL, upper lid. LL, lower lid. 
 
Figure 1. Lamellar ichthyosis. Congenital cicatricial ectropion of the lower 
eyelids. 
 
 
Figure 2. Involutional ectropion: A) total; B) medial; C) lateral. 
 
 
 
Figure 2. Cicatricial ectropion caused by an excision of basal cell carcinoma of the 
lower eyelid. 
 
 
 
 
Figure 4. Left lower lid paralytic ectropion. Note lower lid laxity and ectropion, brow 
ptosis and absence of forehead wrinkles. 
 
 
 
Figure 5. Mechanical ectropion caused by a basal cell carcinoma. 
 
 
 
Figure 6. Lacrimal ectropion of the right lower eyelid (top) corrected with a Lazy-T 
procedure (bottom). 
 
 
 
Figure 7. Left involutional lower lid ectropion. Top: Preoperative appearence. 
Bottom: postoperative (tarsal strip) result. 
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● For purely black and white images, such as line graphs and artistic renderings.  
● 300 DPI/PPI for halftones (CMYK/grayscale).  
For color or black-and-white images containing pictures only, including photographs not 
containing text labeling or thin lines.  
● 600 DPI/PPI for combination halftones (CMYK/grayscale)  
For color or black-and-white images containing pictures and text labeling and/or thin lines. 
Lower resolutions may compromise print quality; higher resolutions will not improve output 
quality and will only increase file size. 
Color Mode. Color images must be submitted in CMYK (cyan, magenta, yellow, black) 
mode, not RGB (red, green, blue) mode. Radiographs should be submitted in grayscale 
mode. Black-and-white line art can be submitted in grayscale or bitmap mode. 
Cropping and sizing. All graphics should be submitted at their actual size; that is, they 
should be 100% of their print dimensions so that no scaling is necessary. Images should fit a 
column width of 3.5 inches. Crop figures (or change the pagesize of your document) so that 
no unnecessary white space is left bordering the figure. 
Line Art. Line art must be submitted as a TIFF file at a resolution of 1200 dpi. If prepared in 
PowerPoint or Excel, line art can be imported into Photoshop and converted to TIFF format or 
can be printed on a photoquality printer and then rescanned at 1200 dpi. 
 
